Technical Analysis for DVAX - Dynavax Technologies Corporation

Grade Last Price % Change Price Change
grade F 12.0 -1.64% -0.20
DVAX closed down 1.64 percent on Friday, September 21, 2018, on 4.59 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical DVAX trend table...

Date Alert Name Type % Chg
Sep 21 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Sep 21 Spinning Top Other 0.00%
Sep 21 Volume Surge Other 0.00%
Sep 20 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.64%
Sep 20 Inside Day Range Contraction -1.64%
Sep 20 Oversold Stochastic Weakness -1.64%
Sep 19 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.42%
Sep 19 New 52 Week Low Weakness 0.42%
Sep 19 Outside Day Range Expansion 0.42%
Sep 19 Lower Bollinger Band Touch Weakness 0.42%

Older signals for DVAX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. It develops product candidates based on the use of immunostimulatory sequences and immunoregulatory sequences. Its lead product candidate is HEPLISAV, a Phase III investigational adult hepatitis B vaccine. The company also develops DV1179, a Phase I bifunctional inhibitor of TLR7 and TLR9 for the treatment of autoimmune and inflammatory diseases; and AZD1419, a preclinical drug candidate for the treatment of asthma. It has a strategic alliance with GlaxoSmithKline to discover, develop, and commercialize TLR inhibitors; and a research collaboration and license agreement with AstraZeneca AB for the discovery and development of TLR9 agonist-based therapies for the treatment of asthma and chronic obstructive pulmonary disease. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is based in Berkeley, California.
Is DVAX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 24.45
52 Week Low 11.35
Average Volume 927,211
200-Day Moving Average 16.3298
50-Day Moving Average 13.3375
20-Day Moving Average 12.7
10-Day Moving Average 12.12
Average True Range 0.5843
ADX 29.63
+DI 10.4298
-DI 23.8508
Chandelier Exit (Long, 3 ATRs ) 12.5971
Chandelier Exit (Short, 3 ATRs ) 13.1029
Upper Bollinger Band 14.0149
Lower Bollinger Band 11.3851
Percent B (%b) 0.23
BandWidth 20.707087
MACD Line -0.4095
MACD Signal Line -0.3868
MACD Histogram -0.0227
Fundamentals Value
Market Cap 658.06 Million
Num Shares 54.8 Million
EPS -2.42
Price-to-Earnings (P/E) Ratio -4.96
Price-to-Sales 143.85
Price-to-Book 7.89
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.74
Resistance 3 (R3) 12.75 12.53 12.61
Resistance 2 (R2) 12.53 12.34 12.52 12.57
Resistance 1 (R1) 12.26 12.22 12.15 12.25 12.53
Pivot Point 12.04 12.04 11.98 12.03 12.04
Support 1 (S1) 11.77 11.85 11.66 11.76 11.47
Support 2 (S2) 11.55 11.73 11.54 11.43
Support 3 (S3) 11.28 11.55 11.39
Support 4 (S4) 11.27